BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884
122 results:

  • 1. Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer.
    Arai H; Yang Y; Baca Y; Millstein J; Denda T; Ou FS; Innocenti F; Takeda H; Kubota Y; Doi A; Horie Y; Umemoto K; Izawa N; Wang J; Battaglin F; Jayachandran P; Algaze S; Soni S; Zhang W; Goldberg RM; Hall MJ; Scott AJ; Hwang JJ; Lou E; Weinberg BA; Marshall J; Goel S; Xiu J; Michael Korn W; Venook AP; Sunakawa Y; Lenz HJ
    Eur J Cancer; 2024 Apr; 201():113914. PubMed ID: 38359495
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Single-cell and transcriptomic analyses reveal the influence of diabetes on ovarian cancer.
    Zhao Z; Wang Q; Zhao F; Ma J; Sui X; Choe HC; Chen P; Gao X; Zhang L
    BMC Genomics; 2024 Jan; 25(1):1. PubMed ID: 38166541
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Rational Combinations of PARP Inhibitors with HRD-Inducing Molecularly Targeted Agents.
    Lee EK; Liu JF
    Cancer Treat Res; 2023; 186():171-188. PubMed ID: 37978136
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center.
    Duan C; Li K; Pan X; Wei Z; Xiao L
    BMC Cancer; 2023 May; 23(1):489. PubMed ID: 37259027
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mass Spectrometry-Based Proteomics of Epithelial ovarian cancers: A Clinical Perspective.
    Qian L; Sun R; Xue Z; Guo T
    Mol Cell Proteomics; 2023 Jul; 22(7):100578. PubMed ID: 37209814
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. hsp90aB1 as the Druggable Target of Maggot Extract Reverses Cisplatin Resistance in ovarian cancer.
    Wang D; Tang X; Ruan J; Zhu Z; Wang R; Weng Y; Zhang Y; Wang T; Huang Y; Wang H; Su Z; Wu X; Tao G; Wang Y
    Oxid Med Cell Longev; 2023; 2023():9335440. PubMed ID: 37180757
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Jinfeng pills ameliorate premature ovarian insufficiency induced by cyclophosphamide in rats and correlate to modulating IL-17A/IL-6 axis and MEK/ERK signals.
    Hu YY; Zhong RH; Guo XJ; Li GT; Zhou JY; Yang WJ; Ren BT; Zhu Y
    J Ethnopharmacol; 2023 May; 307():116242. PubMed ID: 36775079
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Exploring the Antiovarian cancer Mechanisms of Salvia Miltiorrhiza Bunge by Network Pharmacological Analysis and Molecular Docking.
    Xu X; Zhang Z; Liu L; Che C; Li W
    Comput Math Methods Med; 2022; 2022():7895246. PubMed ID: 36483919
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Single-Cell Dissection of the Multiomic Landscape of High-Grade Serous ovarian cancer.
    Wang Y; Xie H; Chang X; Hu W; Li M; Li Y; Liu H; Cheng H; Wang S; Zhou L; Shen D; Dou S; Ma R; Mao Y; Zhu H; Zhang X; Zheng Y; Ye X; Wen L; Kee K; Cui H; Tang F
    Cancer Res; 2022 Nov; 82(21):3903-3916. PubMed ID: 35969151
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Antitumour effects of a solid lipid nanoparticle loaded with gemcitabine and oxaliplatin on the viability, apoptosis, autophagy, and hsp90 of ovarian cancer cells.
    Al-Mutairi AA; Alkhatib MH
    J Microencapsul; 2022 Aug; 39(5):467-480. PubMed ID: 35916335
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. IL-6 secretion of CD4
    Zhu XL; Wang HJ; Wang XR; Wu D; Ji X; Xu L; Yang Q; Guo JY; Rong Y; Pan N; Cai YL
    Clin Transl Oncol; 2022 Nov; 24(11):2222-2230. PubMed ID: 35871126
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Preclinical
    Li Y; Chen Y; Wei M; Wei C
    Front Endocrinol (Lausanne); 2022; 13():845404. PubMed ID: 35464051
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting hsp90aa1 in diffuse malignant peritoneal mesothelioma.
    El Bezawy R; Percio S; Ciniselli CM; De Cesare M; Colella G; Dugo M; Veneroni S; Doldi V; Martini S; Baratti D; Kusamura S; Verderio P; Deraco M; Gandellini P; Zaffaroni N; Zuco V
    Cancer Gene Ther; 2022 Oct; 29(10):1394-1404. PubMed ID: 35352023
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues.
    Moukarzel LA; Ferrando L; Dopeso H; Stylianou A; Basili T; Pareja F; Da Cruz Paula A; Zoppoli G; Abu-Rustum NR; Reis-Filho JS; Long Roche K; Tew WP; Chi DS; Sonoda Y; Zamarin D; Aghajanian C; O'Cearbhaill RE; Zivanovic O; Weigelt B
    Gynecol Oncol; 2022 May; 165(2):239-247. PubMed ID: 35292180
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. JAK2-Mediated Phosphorylation of Stress-Induced Phosphoprotein-1 (STIP1) in Human Cells.
    Chao A; Liao MJ; Chen SH; Lee YS; Tsai CN; Lin CY; Tsai CL
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269562
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Combined PARP and hsp90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours.
    Konstantinopoulos PA; Cheng SC; Supko JG; Polak M; Wahner-Hendrickson AE; Ivy SP; Bowes B; Sawyer H; Basada P; Hayes M; Curtis J; Horowitz N; Wright AA; Campos SM; Ivanova EV; Paweletz CP; Palakurthi S; Liu JF; D'Andrea AD; Gokhale PC; Chowdhury D; Matulonis UA; Shapiro GI
    Br J Cancer; 2022 Apr; 126(7):1027-1036. PubMed ID: 34887522
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Antibody-drug conjugate and free geldanamycin combination therapy enhances anti-cancer efficacy.
    McCombs JR; Chang HP; Shah DK; Owen SC
    Int J Pharm; 2021 Dec; 610():121272. PubMed ID: 34763035
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Lamin-A interacting protein hsp90 is required for DNA damage repair and chemoresistance of ovarian cancer cells.
    Wang Y; Chen Q; Wu D; Chen Q; Gong G; He L; Wu X
    Cell Death Dis; 2021 Aug; 12(8):786. PubMed ID: 34381017
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues.
    Lallier M; Marchandet L; Moukengue B; Charrier C; Baud'huin M; Verrecchia F; Ory B; Lamoureux F
    Cells; 2021 Mar; 10(4):. PubMed ID: 33808130
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Hypochlorous acid selectively promotes toxicity and the expression of danger signals in human abdominal cancer cells.
    Freund E; Miebach L; Stope MB; Bekeschus S
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760187
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.